REFERENCES
- Anonymous. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Annals of Internal Medicine 1980; 93: 391–398
- Hoffman L A, Johnson J T, Wesmiller S W, Sciurba F C, Ferson P F, Mazzocco M C, et al. Transtracheal delivery of oxygen: efficacy and safety for long-term continuous therapy. Ann Otol Rhinol Laryngol 1991; 100: 108–115
- Couser J I, Jr., Make B J. Transtracheal oxygen decreases inspired minute ventilation. Am Rev Respir Dis 1989; 139: 627–631
- Benditt J, Pollock M, Roa J, Celli B. Transtracheal delivery of gas decreases the oxygen cost of breathing. Am Rev Respir Dis 1993; 147: 1207–1210
- Christopher K L, Spofford B T, Petrun M D, McCarty D C, Goodman J R, Petty T L. A program for transtracheal oxygen delivery. Assessment of safety and efficacy. Ann Intern Med 1987; 107: 802–808
- Clifford D MJ, Worley P, Goodman J. Transtracheal oxygen improves survival and reduces hospital costs. Am J Respir Crit Care Med 1995; 1: A681.20
- Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980; 93: 391–398
- Chaouat A, Weitzenblum E, Kessler R, Charpentier C, Ehrhart M, Levi-Valensi P, et al. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur Respir J 1997; 10: 1730–1735
- Zielinski J. Pulmonary gas exchange during sleep in patients with airflow limitation undergoing long-term oxygen therapy. Respir Care 2002; 47: 876–878
- Zielinski J. Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans. Eur Respir J 2005; 25: 173–180
- Morrison D A, Adcock K, Collins C M, Goldman S, Caldwell J H, Schwarz M I. Right ventricular dysfunction and the exercise limitation of chronic obstructive pulmonary disease. J Am Coll Cardiol 1987; 9: 1219–1229
- VanHooser T JS, Winslett L, Christopher K. Comparison of transtracheal augmented ventilation (TTAV) with conventional T-Piece weaning. Respir Care 1993; 38: 1227
- Brack T, Senn O, Russi E W, Bloch K E. Transtracheal high-flow insufflation supports spontaneous respiration in chronic respiratory failure. Chest 2005; 127: 98–104
- Christopher K L, Van Hooser D T, Jorgenson S J, Winslett L, Diehl S S, Young D A, et al. Preliminary observations of transtracheal augmented ventilation for chronic severe respiratory disease. Respir Care 2001; 46: 15–25
- Schneider H, O'Hearn D J, Leblanc K, Smith P L, O'Donnell C P, Eisele D W, et al. High-flow transtracheal insufflation treats obstructive sleep apnea. A pilot study. Amer J Respir Crit Care Med 2000; 161: 1869–1876
- Lipkin A F, Christopher K L, Diehl S, Yaeger E S, Jorgenson S. Otolaryngologist's role in transtracheal oxygen therapy: the minitrach procedure. Otolaryngol Head Neck Surg 1996; 115: 447–453
- Couser J I, Make B J. Respiratory tract infection complicating transtracheal oxygen therapy. Chest 1992; 101: 273–275
- Bloom B S, Daniel J M, Wiseman M, Knorr R S, Cebul R, Kissick W L. Transtracheal oxygen delivery and patients with chronic obstructive pulmonary disease. Respir Med 1989; 83: 281–288